|
|
.
See Category: Neoplasms
See Header: Malignant neoplasm of upper-inner quadrant of breast, male
ICD-10 (CM) Code and Descriptor
|
C50.222 |
Malignant neoplasm of upper-inner quadrant of left male breast
Diagnosis Valid for Male Patient Only
|
C50222 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 61.90%
|
15.75%
|
8.42%
|
4.40%
|
2.56%
|
2.20%
|
1.83%
|
0.37%
|
1.10%
|
1.10%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C50.222*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
59
|
59
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
54
|
54
|
|
80053
|
COMPREHEN METABOLIC PANEL |
52
|
52
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
45
|
45
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
21
|
21
|
|
Q5117
|
INJ., KANJINTI, 10 MG |
18
|
405
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
16
|
16
|
|
77387
|
GUIDANCE FOR RADJ TX DLVR |
15
|
15
|
|
86300
|
IMMUNOASSAY TUMOR CA 15-3 |
13
|
18
|
|
83735
|
ASSAY OF MAGNESIUM |
12
|
12
|
|
82310
|
ASSAY OF CALCIUM |
11
|
11
|
|
J0897
|
DENOSUMAB INJECTION |
11
|
1,320
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
10
|
1,009
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
10
|
10
|
|
82565
|
ASSAY OF CREATININE |
9
|
9
|
|
96413
|
CHEMO IV INFUSION 1 HR |
9
|
9
|
|
71260
|
CT THORAX DX C+ |
8
|
8
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
8
|
8
|
|
82947
|
ASSAY GLUCOSE BLOOD QUANT |
8
|
10
|
|
84100
|
ASSAY OF PHOSPHORUS |
8
|
8
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C50.222 related to the following DRG Codes:
582-583
597-599
|
